Nitric Oxide Synthase Inhibition Reduces Glucose Uptake During Exercise in Individuals With Type 2 Diabetes More Than in Control Subjects
Nitric Oxide Synthase Inhibition Reduces Glucose Uptake During Exercise in Individuals With Type 2 Diabetes More Than in Control Subjects Bronwyn A. Kingwell 1 , Melissa Formosa 1 , Michael Muhlmann 1 , Scott J. Bradley 2 and Glenn K. McConell 3 1 Alfred and Baker Medical Unit, Baker Medical Researc...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 51; no. 8; pp. 2572 - 2580 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.08.2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Nitric Oxide Synthase Inhibition Reduces Glucose Uptake During Exercise in Individuals With Type 2 Diabetes More Than in Control
Subjects
Bronwyn A. Kingwell 1 ,
Melissa Formosa 1 ,
Michael Muhlmann 1 ,
Scott J. Bradley 2 and
Glenn K. McConell 3
1 Alfred and Baker Medical Unit, Baker Medical Research Institute, Prahran, Victoria, Australia
2 School of Physiotherapy, La Trobe University, Bundoora, Victoria, Australia
3 Department of Physiology, Monash University, Clayton, Victoria, Australia
Abstract
Nitric oxide (NO) synthase inhibition reduces leg glucose uptake during cycling without reducing leg blood flow (LBF) in young,
healthy individuals. This study sought to determine the role of NO in glucose uptake during exercise in individuals with type
2 diabetes. Nine men with type 2 diabetes and nine control subjects matched for age, sex, peak pulmonary oxygen uptake ( V o 2 peak), and weight completed two 25-min bouts of cycling exercise at 60 ± 2% V o 2 peak, separated by 90 min. N G -monomethyl- l -arginine ( l -NMMA) (total dose 6 mg/kg) or placebo was administered into the femoral artery for the final 15 min of exercise in a counterbalanced,
blinded, crossover design. LBF was measured by thermodilution in the femoral vein, and leg glucose uptake was calculated as
the product of LBF and femoral arteriovenous glucose difference. During exercise with placebo, glucose uptake was not different
between control subjects and individuals with diabetes; however, LBF was lower and arterial plasma glucose and insulin levels
were higher in individuals with diabetes. l -NMMA had no effect on LBF or arterial plasma glucose and insulin concentrations during exercise in both groups. l -NMMA significantly reduced leg glucose uptake in both groups, with a significantly greater reduction ( P = 0.04) in the diabetic group (75 ± 13%, 5 min after l -NMMA) compared with the control group (34 ± 14%, 5 min after l -NMMA). These data suggest a greater reliance on NO for glucose uptake during exercise in individuals with type 2 diabetes
compared with control subjects.
Footnotes
Address correspondence and reprint requests to Dr. Bronwyn Kingwell, Alfred and Baker Medical Unit, Baker Medical Research
Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne 8008, Australia. E-mail: b.kingwell{at}alfred.org.au .
Received for publication 20 June 2001 and accepted in revised form 10 April 2002.
AMPK, AMP-activated protein kinase; a-v, arteriovenous; eNOS, endothelial nitric oxide synthase; LBF, leg blood flow; l -NMMA, N G -monomethyl- l -arginine; NOS, nitric oxide synthase; NO x , nitrate/nitrite; RER, respiratory exchange ratio; S o 2 , oxygen saturation; STPD, standard temperature and pressure, dry; V o 2 peak, peak pulmonary oxygen uptake.
DIABETES |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.51.8.2572 |